Long-Term Androgen Therapy Increases Cardiovascular Risk in Transgender Men
Transgender men who are on long-term androgen therapy have higher levels of aortic stiffness, which may increase their risk for cardiovascular events.
Transgender men who are on long-term androgen therapy have higher levels of aortic stiffness, which may increase their risk for cardiovascular events.
Linagliptin decreased HbA1c, as well as reactive oxygen species generation and plasma lipid peroxide levels.
The effects of testosterone therapy administered before controlled ovarian stimulation on pregnancy and live birth rates were examined in poor responders undergoing IVF
Please login or register first to view this content.